Viking Therapeutics Statistics
NASDAQ: VKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.73-0.81 (-2.84%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Viking Therapeutics by the numbers
Viking Therapeutics has a market capitalization of $3.53 billion based on 127.17M shares outstanding. With trailing EPS of $-4.67, Viking Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.7% below its 50-day average and 16.1% below its 200-day average.
Average daily trading volume is 4.13M shares, or about $114.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VKTX valuation vs. peer median
| Metric | VKTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.53B | $3.56B | -1% |
| Avg. volume | 4.13M | 2.10M | +97% |
Peer median across 8 companies: OGN, LEGN, XENE, PBLS, TLX, AMLX, ACAD, TNGX.
Valuation
- Market cap
- $3.53B
- EPS (TTM)
- $-4.67
- Shares outstanding
- 127.17M
Price and trading
- Previous close
- 28.54
- Open
- 28.48
- Day range
- 27.05 – 28.49
- 52-week range
- 25.77 – 43.15
- 52-week change
- -14.33%
- Beta
- —
- Volume
- 8.68M
- Average volume
- 4.13M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 3.53B
- Forward Pe
- -6.30
- Eps
- -4.67
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.15
- Week52 Low
- 25.77
- Avg Volume
- 4.13M
- Shares Outstanding
- 127.17M
- Ma50
- 32.89
- Ma200
- 33.04
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -35.74%
- Pct From52w Low
- 7.61%